Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $512.1100 (1.11%) ($512.1100 - $512.1100) on Wed. Jan. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.82% (three month average) | RSI | 61 | Latest Price | $512.1100(1.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.7% a day on average for past five trading days. | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(43%) SPLV(37%) DIA(36%) IVW(36%) | Factors Impacting REGN price | REGN will decline at least -0.91% in a week (0% probabilities). VIXM(-21%) TBT(-7%) VXX(-6%) UUP(-6%) IGOV(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.91% (StdDev 1.82%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $500.37(2.35%) | 10 Day Moving Average | $490.54(4.4%) | 20 Day Moving Average | $490.45(4.42%) | To recent high | -15.7% | To recent low | 9% | Market Cap | $54.298b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |